JLP1 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of GLP-1 Antibodies

GLP-1 antibodies are immunoreagents designed to detect, quantify, or modulate the activity of GLP-1, a 30–31 amino acid peptide hormone involved in glucose homeostasis, insulin secretion, and immune regulation . These antibodies target either the GLP-1 peptide itself or its receptor (GLP-1R), a class B G protein-coupled receptor (GPCR) .

Development and Optimization of GLP-1 Antibodies

Recent advancements in antibody engineering have yielded both antagonistic and agonistic GLP-1R antibodies:

Phage Display and Mutagenesis

  • TB-222-023: A high-potency antagonist derived from phage display libraries, showing 10-fold greater inhibition of cAMP accumulation compared to exendin-(9-39), a traditional GLP-1R antagonist .

  • TAO Algorithm: Twist Antibody Optimization enabled the generation of 444 HCDR3 mutations, leading to improved binding affinity and functional specificity .

Metabolic Regulation

  • Insulin Secretion: GLP-1 antibodies like TB-222-023 reduce glucose-dependent insulin secretion in pancreatic β-cells .

  • β-Cell Protection: Antibodies mimicking GLP-1 activity enhance β-cell proliferation and inhibit apoptosis .

Immunomodulation

  • Macrophage Polarization: GLP-1 analogues (e.g., exenatide, lixisenatide) promote M2 macrophage polarization, reducing inflammation in atherosclerosis and metabolic disorders .

  • Intestinal Immunity: GLP-1R activation in intestinal epithelial lymphocytes (IELs) suppresses pro-inflammatory cytokine production .

Antagonism in Hyperinsulinemia (HI)

  • GLP-1R antagonists like TB-222-023 lower insulin secretion in pancreatic islets, offering therapeutic potential for HI .

Neuroprotection and Cardiovascular Benefits

  • GLP-1R agonists reduce neuroinflammation and improve outcomes in Alzheimer’s and Parkinson’s disease models .

  • Cardiovascular benefits include plaque stabilization and blood pressure regulation .

Limitations and Challenges

  • Short Half-Life: Endogenous GLP-1 has a 2-minute half-life due to DPP-4 cleavage, necessitating engineered antibodies for sustained activity .

  • Tissue-Specific Effects: Off-target activation in non-pancreatic tissues (e.g., brain, kidneys) requires precise targeting .

Future Directions

  • Long-Acting Formulations: Development of oral or depot formulations to enhance bioavailability .

  • Dual-Target Antibodies: Combining GLP-1R modulation with anti-inflammatory or anti-apoptotic pathways .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
JLP1 antibody; YLL057C antibody; L0572 antibody; Alpha-ketoglutarate-dependent sulfonate dioxygenase antibody; EC 1.14.11.- antibody
Target Names
JLP1
Uniprot No.

Target Background

Function
JLP1 antibody targets an enzyme that functions as an alpha-ketoglutarate-dependent dioxygenase, specifically acting on sulfonates. While taurine is a relatively poor substrate, the enzyme efficiently utilizes various other sulfonates. The most prominent natural substrates include isethionate and taurocholate.
Gene References Into Functions
  1. A potential role for the JLP1 enzyme has been suggested in paraganglioma oncogenesis, particularly through its inhibition by succinate. PMID: 17884808
Database Links

KEGG: sce:YLL057C

STRING: 4932.YLL057C

Protein Families
TfdA dioxygenase family

Q&A

What is JLP1 protein and what are its known functions in yeast?

JLP1 (Q12358) is a protein found in Saccharomyces cerevisiae (Baker's yeast). It functions primarily in cellular processes specific to yeast metabolism. While detailed functional characterization is still evolving in current research, it belongs to a family of proteins that may be involved in stress responses and cellular adaptation mechanisms. Studies investigating JLP1 typically use antibody-based detection methods to elucidate its expression patterns under various experimental conditions.

What are the key specifications of commercially available JLP1 antibodies?

The JLP1 antibody (CSB-PA622466XA01SVG) is a rabbit polyclonal antibody raised against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) JLP1 protein. It has been validated for ELISA and Western blot applications. The antibody is purified using Protein A/G methodology, which provides high specificity for the target protein . The corresponding JLP1 gene has an Entrez Gene ID of 850669 and UniProt accession number Q12358 .

What immunodetection techniques are appropriate for JLP1 antibody?

Based on supplier validation data, JLP1 antibody is suitable for both ELISA and Western blot applications . For Western blotting, researchers should follow standard protocols incorporating appropriate blocking agents and detection systems compatible with rabbit-derived antibodies. ELISA applications can utilize either direct or sandwich formats, leveraging the polyclonal nature of the antibody to capture multiple epitopes of the JLP1 protein.

What is the optimal protocol for Western blot detection using JLP1 antibody?

A methodologically sound Western blot protocol for JLP1 detection includes:

  • Sample preparation: Lyse yeast cells in buffer containing protease inhibitors

  • Protein separation: Run 20-50 μg total protein on SDS-PAGE (10-12%)

  • Transfer: Use PVDF membrane with standard transfer buffer

  • Blocking: 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

  • Primary antibody: Dilute JLP1 antibody 1:1000 in blocking buffer; incubate overnight at 4°C

  • Washing: 3-5 washes with TBST, 5-10 minutes each

  • Secondary antibody: Anti-rabbit HRP conjugate (1:5000); incubate 1 hour at room temperature

  • Detection: Use ECL substrate and image according to standard protocols

Include appropriate positive controls using the recombinant immunogen protein provided with the antibody package .

How should researchers validate JLP1 antibody specificity?

Rigorous antibody validation should include:

  • Positive control: Use the supplied recombinant immunogen protein (200 μg provided in antibody package)

  • Negative control: Utilize pre-immune serum (1 ml provided) to establish background signal levels

  • Knockdown/knockout validation: Compare antibody signal in wild-type vs. JLP1 knockout yeast strains

  • Cross-reactivity assessment: Test antibody against related yeast proteins

  • Peptide competition: Pre-incubate antibody with purified JLP1 protein to block specific binding

Methodical validation establishes confidence in experimental results and addresses potential specificity concerns that might compromise data interpretation.

What sample preparation methods yield optimal results for yeast JLP1 detection?

For effective JLP1 detection from yeast samples:

  • Culture conditions: Standardize growth phase and media composition

  • Cell disruption: Use glass bead lysis in buffer containing:

    • 50 mM Tris-HCl, pH 7.5

    • 150 mM NaCl

    • 1% Triton X-100

    • 1 mM EDTA

    • Protease inhibitor cocktail

  • Centrifugation: 13,000 × g for 15 minutes at 4°C to remove cell debris

  • Protein quantification: Bradford or BCA assay

  • Sample handling: Add reducing agent (DTT or β-mercaptoethanol) to samples immediately before denaturation

  • Denaturation: Heat samples at 95°C for 5 minutes in Laemmli buffer

Consistency in sample preparation is crucial for reproducible results when studying JLP1 expression under different experimental conditions.

How can JLP1 antibody be used in immunoprecipitation studies?

For effective immunoprecipitation of JLP1:

  • Pre-clear lysate: Incubate with Protein A/G beads (1 hour at 4°C)

  • Antibody binding: Add 2-5 μg JLP1 antibody to 500 μg protein lysate; incubate overnight at 4°C

  • Capture: Add 40 μl Protein A/G beads; incubate 2-4 hours at 4°C

  • Washing: 4-5 washes with IP buffer containing reduced detergent

  • Elution: SDS sample buffer at 95°C for 5 minutes

  • Analysis: Western blot with a different JLP1 antibody or mass spectrometry

This approach enables studies of JLP1 protein interactions and post-translational modifications in different physiological conditions.

What approaches can identify JLP1 protein-protein interactions in yeast?

Multiple complementary approaches can elucidate JLP1 interaction networks:

  • Co-immunoprecipitation: Use JLP1 antibody to pull down protein complexes for mass spectrometry analysis

  • Proximity labeling: Express JLP1 fused to BioID or APEX2 for capturing proximal proteins

  • Yeast two-hybrid screening: Use JLP1 as bait to identify potential interaction partners

  • Cross-linking mass spectrometry: Capture transient interactions through chemical cross-linking

  • Fluorescence resonance energy transfer (FRET): Monitor direct protein interactions in live cells

Combining these methodologies provides robust validation of interaction partners and insights into JLP1 function within cellular pathways.

How should researchers approach subcellular localization studies for JLP1?

For accurate subcellular localization determination:

  • Immunofluorescence:

    • Fix yeast cells with 4% paraformaldehyde

    • Permeabilize with zymolyase followed by 0.1% Triton X-100

    • Block with 3% BSA in PBS

    • Incubate with JLP1 antibody (1:200 dilution)

    • Use fluorophore-conjugated secondary antibody

    • Include markers for cellular compartments (ER, mitochondria, nucleus)

  • Subcellular fractionation:

    • Separate cellular compartments by differential centrifugation

    • Analyze fractions by Western blot using JLP1 antibody

    • Include compartment-specific marker proteins as controls

  • Live cell imaging:

    • Generate strains expressing JLP1-GFP fusion proteins

    • Validate fusion protein functionality

    • Monitor localization under various stress conditions

These approaches provide complementary data on JLP1 localization patterns and potential translocation events.

How should researchers address non-specific binding with JLP1 antibody?

Non-specific binding can be mitigated through systematic optimization:

  • Increase blocking stringency: Use 5% BSA instead of milk; add 0.1-0.3% Tween-20

  • Optimize antibody concentration: Perform titration experiments (1:500 to 1:5000)

  • Modify washing conditions: Increase wash buffer stringency with higher salt concentration (up to 500 mM NaCl)

  • Pre-adsorb antibody: Incubate with lysate from JLP1-knockout yeast to remove cross-reactive antibodies

  • Use alternative blocking agents: Try commercial blocking reagents specifically designed for yeast applications

Careful optimization minimizes background while preserving specific JLP1 signal.

How can researchers validate contradictory results between different detection methods?

When facing contradictory results:

  • Verify antibody lot consistency: Different lots may exhibit variable specificity

  • Confirm protein identity: Perform mass spectrometry on detected bands

  • Evaluate technique-specific artifacts: Some methods may detect denatured vs. native conformations

  • Assess post-translational modifications: Different methods may preferentially detect modified forms

  • Consider cellular context: Expression levels and localization may vary with experimental conditions

  • Validate with orthogonal approaches: Use JLP1 tagging or quantitative PCR to confirm protein expression patterns

Systematic investigation of discrepancies often reveals important biological insights about protein behavior under different experimental conditions.

What controls are essential when investigating JLP1 expression under stress conditions?

Rigorous experimental design requires:

  • Loading controls: Use constitutively expressed proteins (e.g., actin, GAPDH) to normalize expression

  • Time course controls: Monitor expression at multiple time points to capture transient changes

  • Dose-response analysis: Evaluate multiple stress intensities to establish threshold responses

  • Strain controls: Compare wild-type with regulatory mutants affecting stress response pathways

  • Genetic validation: Confirm antibody specificity using JLP1 deletion strains

  • Cross-stress analysis: Compare responses across different stressors to identify specific vs. general responses

These controls establish causality between stress conditions and observed JLP1 expression changes.

How can JLP1 antibody facilitate chromatin-associated protein studies?

For chromatin immunoprecipitation (ChIP) applications:

  • Cross-linking: Treat yeast cells with 1% formaldehyde for 10-15 minutes

  • Chromatin preparation: Lyse cells and sonicate to generate 200-500 bp DNA fragments

  • Immunoprecipitation: Use 5-10 μg JLP1 antibody with Protein A/G beads

  • Washing: Use increasingly stringent buffers to remove non-specific interactions

  • Reverse cross-linking: Incubate samples at 65°C overnight

  • DNA purification: Extract DNA for PCR or sequencing analysis

  • Controls: Include input DNA, IgG control, and positive control for known DNA-binding proteins

This approach can identify potential DNA-binding activities or chromatin associations of JLP1 in yeast.

What methods allow quantitative assessment of JLP1 post-translational modifications?

To investigate JLP1 post-translational modifications:

  • Phosphorylation analysis:

    • Immunoprecipitate JLP1 using the specific antibody

    • Detect phosphorylation using phospho-specific antibodies or Phos-tag gels

    • Confirm with mass spectrometry to identify specific modified residues

  • Ubiquitination studies:

    • Co-immunoprecipitate with anti-ubiquitin and anti-JLP1 antibodies

    • Use deubiquitinase inhibitors during sample preparation

    • Detect ubiquitinated forms via Western blot

  • Glycosylation assessment:

    • Treat samples with glycosidases before Western blotting

    • Use lectin-based affinity purification coupled with JLP1 immunodetection

Quantification of modification stoichiometry provides insights into regulatory mechanisms affecting JLP1 function.

How can researchers design experiments to investigate JLP1 function in protein quality control?

To explore potential roles in protein quality control:

  • Stress induction experiments:

    • Expose yeast to protein-misfolding stressors (heat shock, tunicamycin, DTT)

    • Monitor JLP1 expression and localization changes using the antibody

    • Correlate with unfolded protein response markers

  • Genetic interaction studies:

    • Create double mutants with known quality control genes

    • Assess synthetic phenotypes under stress conditions

    • Use JLP1 antibody to monitor protein levels in different genetic backgrounds

  • Proteasome inhibition:

    • Treat cells with MG132 or bortezomib

    • Monitor JLP1 levels and modification state

    • Assess co-localization with accumulated ubiquitinated proteins

These approaches can reveal functional connections between JLP1 and cellular protein quality control mechanisms.

What detection systems provide optimal sensitivity for low-abundance JLP1?

For detecting low-abundance JLP1:

  • Enhanced chemiluminescence (ECL):

    • Use high-sensitivity ECL substrates

    • Optimize exposure times with incremental imaging

    • Consider signal accumulation with multiple exposures

  • Fluorescent detection:

    • Use near-infrared fluorescent secondary antibodies

    • Leverage multi-channel detection for simultaneous imaging of controls

    • Quantify signals using calibrated imaging systems

  • Amplification systems:

    • Employ tyramide signal amplification

    • Use biotin-streptavidin systems to enhance signal

    • Consider polymer-based detection systems for signal enhancement

Selecting the appropriate detection system based on expected expression levels ensures reliable JLP1 quantification.

How should researchers approach statistical analysis of JLP1 expression data?

Robust statistical analysis requires:

  • Experimental design:

    • Perform at least three biological replicates

    • Include technical replicates for Western blot and ELISA

    • Standardize sample preparation and loading

  • Quantification methods:

    • Use densitometry software with background subtraction

    • Normalize to appropriate loading controls

    • Generate standard curves for absolute quantification

  • Statistical testing:

    • Apply appropriate tests based on data distribution (parametric vs. non-parametric)

    • Account for multiple comparisons when analyzing multiple conditions

    • Report effect sizes along with p-values

  • Data presentation:

    • Include representative blot images alongside quantification

    • Present normalized data with appropriate error bars

    • Indicate sample sizes and statistical significance levels

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.